Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 30/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 |
|---|---|---|---|---|
| Research and development | — | 41,066 | 12,000 | 33,733 |
| Selling, general and administrative | 1M | 380,746 | 518,824 | 129,415 |
| Interest expense | −12M | −6M | −16M | 11M |
| Income tax | — | 0 | −109,750 | −109,745 |
| Net income | −16M | −7M | −15M | 9M |
| Weighted average shares | 5M | 2M | 1M | 16M |
| Metric | 19/08/2026 | 18/08/2026 | 30/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | — | 18M | 3M | 4M | 24M | — |
| Current assets | — | — | 22M |
| Metric | 30/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 |
|---|---|---|---|---|
| Operating cash flow | — | −4M | −10M | −3M |
| Share-based compensation | 361,977 | 953,845 | 3M | 8M |
| Investing cash flow | −21M | −4M | −9M | −6M |
| Financing cash flow |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 3M |
| 5M |
| — |
| — |
| Total assets | — | — | 78M | 30M | 26M | — | — |
| Current liabilities | — | — | 7M | 2M | 4M | 2M | — |
| Total liabilities | — | — | 12M | 4M | 4M | — | — |
| Equity | — | — | 66M | 25M | 23M | 35M | 5M |
| 46M |
| 7M |
| −191,307 |
| 33M |